MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
0.3525
-0.0235
-6.25%
After Hours: 0.3614 +0.0089 +2.52% 19:54 06/12 EDT
OPEN
0.3642
PREV CLOSE
0.3760
HIGH
0.3794
LOW
0.3496
VOLUME
828.15K
TURNOVER
--
52 WEEK HIGH
2.045
52 WEEK LOW
0.1593
MARKET CAP
8.98M
P/E (TTM)
-0.3240
1D
5D
1M
3M
1Y
5Y
1D
BioRestorative Revamps Board Following New Loan Agreement
TipRanks · 1d ago
BioRestorative Therapies Finalizes Executive Agreement with R&D VP
TipRanks · 1d ago
BioRestorative adds lender designees Grasso, Field, Dhaliwal to board after three director resignations
PUBT · 1d ago
Weekly Report: what happened at BRTX last week (0601-0605)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 06/04 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 06/03 21:07
BioRestorative publishes investor presentation on BRTX-100 stem cell therapy for chronic lumbar disc disease
PUBT · 06/01 17:49
Weekly Report: what happened at BRTX last week (0525-0529)?
Weekly Report · 06/01 09:19
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.